Science Explorer Back to mapMap
Discussion
Researcher · Cyclacel Pharmaceuticals (United Kingdom) · United Kingdom

Athos Gianella-Borradori

Athos Gianella-Borradori publishes mostly in Oncology, Hematology and Molecular Biology, on topics such as Cancer-related Molecular Pathways, Advanced Breast Cancer Therapies and Microtubule and mitosis dynamics.

OpenAlex
World rank
#889,549
of 7,710,434 ranked researchers
Rank in United Kingdom
#73,107
of 367,258
Works
61
Citations
3.8k
Citations per work
63.1
h-index
24
i10-index 39Top 17% in Oncology
Athos Gianella-Borradori

What does Athos Gianella-Borradori research?

Athos Gianella-Borradori's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (10%).

Health Sciences: 30 works · 48.9% of their workMedicine: 30 works · 48.9% of their workOncology: 10 works · 16.5% of their workHematology: 7 works · 11.9% of their workPulmonary and Respiratory Medicine: 5 works · 7.4% of their workPathology and Forensic Medicine: 4 works · 6.8% of their workRadiology, Nuclear Medicine and Imaging: 4 works · 6.3% of their workEverything else: 25 works · 41.4% of their workLife Sciences: 6 works · 9.7% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 9.7% of their workMolecular Biology: 6 works · 9.7% of their workTHEIR WORKAthosGianella-Borradori61works
Life Sciences10%Health Sciences49%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3048.9%
  2. Everything else2541.4%
    1. Biochemistry, Genetics and Molecular Biology69.7%
  1. 1Oncology16% of their works
  2. 2Hematology12% of their works
  3. 3Molecular Biology10% of their works
  4. 4Pulmonary and Respiratory Medicine7% of their works
  5. 5Pathology and Forensic Medicine7% of their works
  6. 6Radiology, Nuclear Medicine and Imaging6% of their works

Research topics

Which keywords describe Athos Gianella-Borradori's research?

The keywords of their largest research topics: Cancer Therapy, Mutation, Metastatic Breast Cancer, Cell Cycle, p53, Prognostic Factors, Breast Cancer and CDK4/6 Inhibitors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Cancer Therapy232 topics
  2. Mutation202 topics
  3. Metastatic Breast Cancer152 topics
  4. Cell Cycle141 topic
  5. Prognostic Factors142 topics
  6. p53141 topic
  7. Breast Cancer101 topic
  8. CDK4/6 Inhibitors101 topic
  9. Cell Division91 topic
  10. Microtubules91 topic
  11. AML81 topic
  12. Acute Myeloid Leukemia81 topic
  13. Fc Receptors71 topic
  14. Therapeutic Antibodies71 topic
  15. BCR-ABL61 topic
  16. Chronic Lymphocytic Leukemia61 topic
  17. Genomic Aberrations61 topic
  18. Imatinib61 topic
  19. Chemotherapy-Induced Peripheral Neuropathy51 topic
  20. Taxanes51 topic

Where does Athos Gianella-Borradori work?

Athos Gianella-Borradori's main affiliation in the publication record is Cyclacel Pharmaceuticals (United Kingdom), United Kingdom.

How many publications and citations does Athos Gianella-Borradori have?

OpenAlex counts 61 works and 3,849 citations for Athos Gianella-Borradori, an h-index of 24, ranking #889,549 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Athos Gianella-Borradori. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.